2025-03-29 09:08:44
Latest Post
Unifinz Capital India Limited declares interim dividend of Rs. 0.50
Suprajit Completes Second Tranche of SCS Acquisition
Ceigall Ayodhya Bypass Pvt Ltd receives appointed date from NHAI
Lemon Tree Hotels signs a new property in Maharashtra
Karur Vysya Bank inaugurates 4 new branches today, 3 in TN and 1 in AP
Stock Report
Metropolis Healthcare Limited - Q2FY25 Business Update
Posted On : 2024-10-04 22:57:07( TIMEZONE : IST )
This update seeks to provide an overall summary of the operating performance and demand trends witnessed during the quarter ended September 30, 2024. A detailed information update will follow once the Board of Directors approves the financial results for Q2FY25.
The Company has been able to deliver strong results in Q2FY25 driven by a combination of increased volumes, product mix change and realizations benefits. Continued momentum from its Truhealth packages, along with successful upselling of bundled packages, led to higher test per patient, contributing to overall revenue growth.
Margins for Q2FY25 have expanded on a sequential basis in line with commentary provided earlier. The Company continues to see a gradual uptick in margins on account of operating leverage, cost optimization and growing contribution from its ongoing network expansion.
Key Highlights of Q2FY25:
- Revenues grew by ~13% on a Y-o-Y basis.
- Revenue growth was driven by patient volume growth, test volume growth and change in product mix coupled with realization benefits.
- B2C revenues grew at ~20% on a Y-o-Y basis on account of industry-leading testing capabilities and strong brand appeal among end consumers.
- Truhealth wellness and bundling segment is the fastest-growing segment.
- Company has added 6 labs and 120 centers in Q2FY25 and increased the presence to a total of ~700 towns in Q2FY25 compared to ~650 towns in FY24.
- Company is debt free with cash reserves in excess of INR 180 crores as on September 30, 2024.
The quarterly business update is on a consolidated basis. The financial results of Q2FY25 is subject to review by Auditors.
Shares of Metropolis Healthcare Limited was last trading in BSE at Rs. 2234.45 as compared to the previous close of Rs. 2241.95. The total number of shares traded during the day was 5335 in over 1254 trades.
The stock hit an intraday high of Rs. 2297.40 and intraday low of 2223.70. The net turnover during the day was Rs. 12110175.00.
